Total Funding
31
6
Total FundingSeries A raised
Growth Score
-2 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
383859
Recardio is a life science company that focuses on drug-based regenerative therapeutic modalities for treatments of cardiovascular diseases.
Frank Ahmann: Chief Operating OfficerPast Role: MateraCor, Chief Executive Officer- Darrell Nix: Chief Scientific Officer
About the Company
Recardio is a clinical-stage life science business focused on cardiovascular, cancer, and infectious disease medicines. The company focuses on developing regenerative therapeutic modalities that use a protein that is essential for cardiac regeneration, allowing patients with various cardiovascular diseases, such as acute myocardial infarction and
chronic heart failure, to improve heart function, quality of life, and survival.
